Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial Fibrillation.
CONCLUSIONS: Rivaroxaban appeared at least as effective and safe as warfarin when used to manage African American patients with NVAF in routine practice.
PMID: 32493618 [PubMed - as supplied by publisher]
Source: Journal of the National Medical Association - Category: General Medicine Tags: J Natl Med Assoc Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Electronic Health Records (EHR) | Gastroenterology | General Medicine | Hemorrhagic Stroke | Ischemic Stroke | Stroke | Warfarin